Description of Mifepristone CAS 84371-65-3
Product name | Mifepristone |
Appearance | white solid |
Purity | 99%min |
CAS No. | 84371-65-3 |
EINECS No. | 617-559-7 |
MF. | C29H35NO2 |
Grade Standard | Medicine Grade |
Introduction for Mifepristone CAS 84371-65-3
Product name:Mifepristone
English Synonyms: 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-9-dien-3-one;11beta-[4-(n,n-dimethylamino)phenyl]-17alpha-(prop-1-ynyl)-delta4,9-estradiene;17-beta)-(11-bet;17beta)-11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)estra-(11bet;17-beta-hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oest;-17beta-ol-3-one;4,9-dien-3-one;r38486
CAS NO.: 84371-65-3
Assay: 98%
Molecular Formula:C29H35NO2
Molecular Weight:429.59
Melting point: 150ºC
Appearance: Light yellowish powder
Packing:1kg/tin
Usage: New anti-progesterone, and has anti-glucocorticoid activity, but not progesterone, estrogen, androgen and anti-estrogen activity. And progesterone receptor affinity 5-fold stronger than progesterone. For anti-early pregnancy, reminders by only pregnancy, fetal death, uterine induction of labor, etc.
Mifepristone was the first antiprogestin to be developed and it has been evaluated extensively for its use as an abortifacient. The original target for the research group, however, was the discovery and development of compounds with antiglucocorticoid properties. These antiglucocorticoid properties are of great interest in the treatment of severe mood disorders and psychosis, although a review of published articles was inconclusive on their efficacy, and considered the use of these drugs in mood disorders at 'proof of concept' stage. It is on the World Health Organization's List of Essential Medicines.